EP Patent

EP3088388A1 — Nitric oxide donating derivatives of prostaglandins

Assigned to Nicox SA · Expires 2016-11-02 · 10y expired

What this patent protects

The present invention relates to nitrooxyderivatives of tafluprost acid, their use for the treatment of glaucoma and ocular hypertension and formulation containing nitrooxyderivatives of tafluprost acid.

USPTO Abstract

The present invention relates to nitrooxyderivatives of tafluprost acid, their use for the treatment of glaucoma and ocular hypertension and formulation containing nitrooxyderivatives of tafluprost acid.

Drugs covered by this patent

Patent Metadata

Patent number
EP3088388A1
Jurisdiction
EP
Classification
—
Expires
2016-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Nicox SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.